LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) updated its third quarter 2026 earnings guidance on Tuesday morning. LeMaitre Vascular also updated its FY 2026 guidance to 2.840-2.940 EPS. Get LeMaitre Vascular alerts:Get Our Latest Report on LMATLeMaitre Vascular Price PerformanceShares of LMAT traded up $2.17 on Tuesday, hitting $105.78. LeMaitre Vascular Company Profile(Get Free Report)LeMaitre Vascular, Inc is a specialty medical device company focused on the development, manufacture and marketing of products for the treatment of peripheral vascular disease. Founded in 1983 by George D.Read MoreReceive News & Ratings for LeMaitre Vascular Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LeMaitre Vascular and related companies with MarketBeat.com's FREE daily email newsletter.